IL-10 associated with GBM is shown to enhance tumor growth (18), inhibit production of IFN-γ and tumor necrosis factor-alpha (TNF-α) by the immune system, downregulate expression of MHC class II in monocytes, and, via the co-stimulatory CD28-CD80/86 pathway, induce anergy in infiltrating T-cells (19, 20). Here, IFNG is linked to neoplasm.